Longtime Pfizer R&D…
Longtime Pfizer R&D chief Kathy Fernando, Ph.D., has left the Big [...]
After a long and strange year,…
After a long and strange year, Belgian biotech Galapagos is [...]
After taking a stab at becoming a…
After taking a stab at becoming a neuroscience biotech, buzzy [...]
Daiichi Sankyo and Merck &…
Daiichi Sankyo and Merck & Co.’s phase 3 program for [...]
Eli Lilly has shown patients…
Eli Lilly has shown patients maintained most of their weight [...]
GSK is embarking on a journey with…
GSK is embarking on a journey with CAMP4 Therapeutics, paying [...]
Takeda’s closely watched and…
Takeda’s closely watched and highly valued dermatology pill zasocitinib has [...]
Bristol Myers Squibb has become…
Bristol Myers Squibb has become the latest Big Pharma to [...]
University of California spinout…
University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” [...]
Nektar Therapeutics is planning to…
Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate [...]